Breast Cancer

Molecular Breast Imaging Proves Cost-Effective for Presurgical Planning in Patients with Breast Cancer

Published in Medical Device Business Week, December 17th, 2008

Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique that is substantially less expensive than breast magnetic resonance imaging (MRI) with comparable sensitivity for detecting breast carcinoma when used in presurgical planning for patients with known cancer diagnoses, according to findings presented today at the annual meeting of the Radiological Society of North America (RSNA).

"According to the national Medicare average, BSGI costs $219.43 compared to $994.43 for breast MRI. Since BSGI has some advantages over MRI, including higher patient tolerance and significant cost savings, BSGI should be considered an alternative for preoperative planning...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week

Source: Medical Device Business Week (2008-12-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry